{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T05:06:32Z","timestamp":1777871192301,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jaad.2025.01.091","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T02:47:02Z","timestamp":1738637222000},"page":"1288-1294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Same-day human papilloma virus vaccination improves vaccine uptake in a dermatology sexually transmitted infection clinic: A quality improvement-based model for improving vaccination rates"],"prefix":"10.1016","volume":"92","author":[{"given":"Jaclyn Rosenthal","family":"Himeles","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Costner","family":"McKenzie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia","family":"Manduca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina S.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zina","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arielle","family":"Nagler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam Keltz","family":"Pomeranz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John G.","family":"Zampella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jaad.2025.01.091_bib1","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/OLQ.0000000000001355","article-title":"Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2018","volume":"48","author":"Kreisel","year":"2021","journal-title":"Sex Transm Dis"},{"issue":"3","key":"10.1016\/j.jaad.2025.01.091_bib2","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3390\/vaccines8030391","article-title":"Human papillomavirus vaccines: an updated review","volume":"8","author":"Cheng","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.jaad.2025.01.091_bib3","doi-asserted-by":"crossref","first-page":"2016007","DOI":"10.1080\/21645515.2021.2016007","article-title":"Review of human papillomavirus (HPV) burden and HPV vaccination for gay, bisexual, and other men who have sex with men and transgender women in the United States","volume":"18","author":"Meites","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jaad.2025.01.091_bib4","article-title":"Increased disparities associated with black women and abnormal cervical cancer screening follow-up","volume":"42","author":"Boitano","year":"2022","journal-title":"Gynecol Oncol Rep"},{"issue":"14","key":"10.1016\/j.jaad.2025.01.091_bib5","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1016\/j.vaccine.2023.02.049","article-title":"Updated estimate of the annual direct medical cost of screening and treatment for human papillomavirus associated disease in the United States","volume":"41","author":"Clay","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.jaad.2025.01.091_bib6","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3389\/fimmu.2020.00188","article-title":"The use of both therapeutic and prophylactic vaccines in the therapy of papillomavirus disease","volume":"11","author":"Garbuglia","year":"2020","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.jaad.2025.01.091_bib7","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1590\/s1677-5538.ibju.2018.0355","article-title":"Can quadrivalent human papillomavirus prophylactic vaccine be an effective alternative for the therapeutic management of genital warts? an exploratory study","volume":"45","author":"Choi","year":"2019","journal-title":"Int Braz J Urol"},{"issue":"12","key":"10.1016\/j.jaad.2025.01.091_bib8","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jamadermatol.2015.2805","article-title":"Effect of quadrivalent human papillomavirus vaccination on oral squamous cell papillomas","volume":"151","author":"Cyrus","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2025.01.091_bib9","doi-asserted-by":"crossref","first-page":"e13771","DOI":"10.1111\/dth.13771","article-title":"Nonavalent human papillomavirus vaccination as alternative treatment for genital warts","volume":"33","author":"Bossart","year":"2020","journal-title":"Dermatol Ther"},{"issue":"24","key":"10.1016\/j.jaad.2025.01.091_bib10","doi-asserted-by":"crossref","first-page":"7592","DOI":"10.3390\/jcm12247592","article-title":"Effect of HPV vaccination on virus disappearance in cervical samples of a cohort of HPV-positive polish patients","volume":"12","author":"Pruski","year":"2023","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.jaad.2025.01.091_bib11","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3390\/vaccines11020443","article-title":"HPV vaccination adherence in working-age men: a systematic review and meta-analysis","volume":"11","author":"Amantea","year":"2023","journal-title":"Vaccines (Basel)"},{"issue":"5","key":"10.1016\/j.jaad.2025.01.091_bib12","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1007\/s40615-020-00886-5","article-title":"Race, nativity, and sex disparities in human papillomavirus vaccination among young adults in the USA","volume":"8","author":"McElfish","year":"2021","journal-title":"J Racial Ethn Health Disparities"},{"key":"10.1016\/j.jaad.2025.01.091_bib13","article-title":"Barriers to human papillomavirus (HPV) vaccination among young adults, aged 18\u201335","volume":"29","author":"Muthukrishnan","year":"2022","journal-title":"Prev Med Rep"},{"issue":"2","key":"10.1016\/j.jaad.2025.01.091_bib14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.pcl.2022.11.001","article-title":"State of vaccine hesitancy in the United States","volume":"70","author":"Nowak","year":"2023","journal-title":"Pediatr Clin North Am"},{"issue":"3-4","key":"10.1016\/j.jaad.2025.01.091_bib15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/jocn.15579","article-title":"Strategies to improve human papillomavirus vaccination rates among adolescents in family practice settings in the United States: a systematic review","volume":"30","author":"Eisenhauer","year":"2021","journal-title":"J Clin Nurs"},{"issue":"12","key":"10.1016\/j.jaad.2025.01.091_bib16","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1136\/bmjqs-2015-004411","article-title":"SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process","volume":"25","author":"Ogrinc","year":"2016","journal-title":"BMJ Qual Saf"},{"issue":"41","key":"10.1016\/j.jaad.2025.01.091_bib17","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2018.23.41.1700737","article-title":"The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?","volume":"23","author":"Patel","year":"2018","journal-title":"Euro Surveill"},{"issue":"5","key":"10.1016\/j.jaad.2025.01.091_bib18","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2022-058029","article-title":"Provider-based HPV vaccine promotion interventions: a meta-analysis","volume":"151","author":"Wu","year":"2023","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.jaad.2025.01.091_bib19","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1158\/1055-9965.EPI-11-0267","article-title":"Understanding suboptimal human papillomavirus vaccine uptake among ethnic minority girls","volume":"20","author":"Bastani","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"10.1016\/j.jaad.2025.01.091_bib20","doi-asserted-by":"crossref","first-page":"E307","DOI":"10.1097\/PHH.0000000000001253","article-title":"Public education interventions and uptake of human papillomavirus vaccine: a systematic review","volume":"28","author":"Rani","year":"2022","journal-title":"J Publ Health Manag Pract"},{"issue":"5","key":"10.1016\/j.jaad.2025.01.091_bib21","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1542\/peds.2015-1563","article-title":"Promoting HPV vaccination in safety-net clinics: a randomized trial","volume":"136","author":"Tiro","year":"2015","journal-title":"Pediatrics"},{"issue":"16","key":"10.1016\/j.jaad.2025.01.091_bib22","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/j.vaccine.2013.02.046","article-title":"Proximity to safety-net clinics and HPV vaccine uptake among low-income, ethnic minority girls","volume":"31","author":"Tsui","year":"2013","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jaad.2025.01.091_bib23","doi-asserted-by":"crossref","first-page":"2313249","DOI":"10.1080\/21645515.2024.2313249","article-title":"Racial and ethnic disparities in human papillomavirus (HPV) vaccine uptake among United States adults, aged 27\u201345 years","volume":"20","author":"Rincon","year":"2024","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"10.1016\/j.jaad.2025.01.091_bib24","doi-asserted-by":"crossref","first-page":"2264596","DOI":"10.1080\/21645515.2023.2264596","article-title":"Barriers and determinants of consistent offering of HPV vaccination by healthcare facilities","volume":"19","author":"Osaghae","year":"2023","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.jaad.2025.01.091_bib25","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/0284186X.2020.1827158","article-title":"A petition for all patients with hidradenitis suppurativa to receive the HPV vaccine","volume":"60","author":"Deutsch","year":"2021","journal-title":"Acta Oncol (Madr)"},{"issue":"4","key":"10.1016\/j.jaad.2025.01.091_bib26","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/LGT.0000000000000147","article-title":"Atopic dermatitis is associated with cervical high risk human papillomavirus infection","volume":"19","author":"Morgan","year":"2015","journal-title":"J Low Genit Tract Dis"},{"issue":"7","key":"10.1016\/j.jaad.2025.01.091_bib27","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.revmed.2020.12.009","article-title":"Human papillomavirus and systemic lupus erythematosus","volume":"42","author":"David","year":"2021","journal-title":"Rev Med Interne"},{"issue":"suppl_5","key":"10.1016\/j.jaad.2025.01.091_bib28","doi-asserted-by":"crossref","first-page":"v26","DOI":"10.1093\/rheumatology\/kex523","article-title":"Risk of human papillomavirus infection in women with rheumatic disease: cervical cancer screening and prevention","volume":"57","author":"Kim","year":"2018","journal-title":"Rheumatology"},{"issue":"50","key":"10.1016\/j.jaad.2025.01.091_bib29","first-page":"645","article-title":"Human papillomavirus vaccines: WHO position paper (2022 update)","volume":"97","year":"2022","journal-title":"Wkly Epidemiol Rec"},{"issue":"5","key":"10.1016\/j.jaad.2025.01.091_bib30","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2100056","article-title":"Efficacy of single-dose human papillomavirus vaccination among young african women","volume":"1","author":"Barnabas","year":"2022","journal-title":"NEJM Evid"},{"issue":"10","key":"10.1016\/j.jaad.2025.01.091_bib31","doi-asserted-by":"crossref","first-page":"e1473","DOI":"10.1016\/S2214-109X(22)00309-6","article-title":"Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trial","volume":"10","author":"Watson-Jones","year":"2022","journal-title":"Lancet Glob Health"},{"issue":"11","key":"10.1016\/j.jaad.2025.01.091_bib32","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/S1470-2045(21)00453-8","article-title":"Vaccine efficacy against persistent human papillomavirus (HPV) 16\/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study","volume":"22","author":"Basu","year":"2021","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.jaad.2025.01.091_bib33","doi-asserted-by":"crossref","first-page":"e654","DOI":"10.1016\/S1473-3099(24)00227-5","article-title":"Evaluation of a single-dose HPV vaccine strategy for promoting vaccine, health, and gender equity","volume":"24","author":"Mercuri","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"10.1016\/j.jaad.2025.01.091_bib35","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/jamadermatol.2022.3500","article-title":"State Medicaid coverage of human papillomavirus vaccination in adults and implications for dermatologists","volume":"158","author":"Goldman","year":"2022","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2025.01.091_bib37","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1370\/afm.2990","article-title":"Reimbursement for HPV vaccine cost in the private sector: a comparison across specialties","volume":"21","author":"Zhu","year":"2023","journal-title":"Ann Fam Med"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225001896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225001896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T17:04:46Z","timestamp":1777568686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962225001896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0190962225001896"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2025.01.091","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Same-day human papilloma virus vaccination improves vaccine uptake in a dermatology sexually transmitted infection clinic: A quality improvement-based model for improving vaccination rates","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2025.01.091","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}